Transforming growth factor beta 1 (TGF beta 1) down-regulates expression and function of proliferation-inducing molecules in HPV-transformed cells
Related Experiment Video
Updated: Oct 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
M K Shier1, E B Neely, M G Ward
1Department of Microbiology and Immunology, Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey 17033, USA.
Abstract:
The epidemiologic association of human papillomavirus (HPV) infection with dysplasia and cervical cancer is well established. Transforming growth factor beta 1 (TGF beta 1) is a growth inhibitory protein for epithelial cells. To examine the phenotype of HPV-transformed cells, we examined expression of TGF beta 1 and a number of cellular proliferation-enhancing molecules which are known to be regulated by TGF beta 1, including bcl-2, c-jun and NFkB. Previous studies had identified significant induction of TGF beta 1 and concomitant down-regulation of other growth stimulatory molecules in experimental papillomas. We used HPV-16 and -18 transformed cell lines. The HPV-16 transformed cells showed down-regulation of bcl-2 and NFkB as well as NFkB function upon TGF beta 1 treatment. The results suggest that TGF beta 1 may exert antiproliferative effects on some HPV-transformed cells by down-regulating expression and function of different proliferation-enhancing molecules. It is uncertain if this function is virus type specific and/or related to state of tumor cell progression.
Insights
Transforming growth factor beta 1 (TGF beta 1) may inhibit human papillomavirus (HPV)-driven cell growth by reducing key proliferation molecules like bcl-2 and NFkB in some HPV-transformed cells.
Area of Science:
- Oncology
- Virology
- Cell Biology
Background:
- Human papillomavirus (HPV) infection is linked to cervical dysplasia and cancer.
- Transforming growth factor beta 1 (TGF beta 1) inhibits epithelial cell growth.
- Previous research indicated TGF beta 1 induction and growth stimulatory molecule downregulation in experimental papillomas.
Purpose of the Study:
- To investigate the phenotype of HPV-transformed cells.
- To examine the expression of TGF beta 1 and its regulation of proliferation-enhancing molecules (bcl-2, c-jun, NFkB).
Main Methods:
- Utilized HPV-16 and HPV-18 transformed cell lines.
- Assessed expression of TGF beta 1, bcl-2, c-jun, and NFkB.
- Evaluated NFkB function following TGF beta 1 treatment.
Main Results:
- HPV-16 transformed cells exhibited TGF beta 1-induced downregulation of bcl-2 and NFkB.
- NFkB function was also reduced in HPV-16 cells upon TGF beta 1 treatment.
Conclusions:
- TGF beta 1 may exert antiproliferative effects on certain HPV-transformed cells.
- This effect is achieved by downregulating key proliferation-enhancing molecules.
- Further research is needed to determine if this is virus type-specific or related to tumor progression stage.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Negative Regulator Molecules
Mitogens and the Cell Cycle
Regulation of Angiogenesis and Blood Supply
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

